- SEK1.26bn
- SEK1.13bn
- SEK441.90m
Brief: C Rad Q1 Adjusted EBIT SEK 22 Mln
Brief: C Rad Q4 Order Intake Decreased 10% To SEK 151 Mln
Brief: C-RAD Appoints Tomas Blomquist As CEO
Brief: C-RAD Q3 EBIT Up At SEK 21.2 Mln
Brief: C-Rad CEO To Leave
Brief: C-Rad Wins Order From From Czech Hospital
Brief: C-Rad, IRT Systems Announce Partnership To Advance Safety In Radiotherapy
Brief: C Rad Order Intake Increased 6% To SEK 134.8 Mln
Brief: C-Rad Gets SEK 8 Mln Order With U.S. Healthcare Provider
Brief: C Rad Signs Contract Valued At SEK 9 Mln
Brief: C Rad Q1 Order Intake Up By 5% To SEK 96.5 Mln
Brief: C Rad Proposes No Dividend Is Paid For 2024 Financial Year
Brief: C Rad Q3 Order Intake Falls To SEK 99.6 Mln
Brief: C-Rad Wins SEK 10 Mln Order
Brief: C Rad Q2 Rev Up At SEK 129.4 Mln
Brief: C Rad To Repurchase Up To 100,000 Own Class B Shares
Brief: C-Rad Appoints Linda Frölén As New CFO
Brief: C-Rad Appoints Jonas Reinhammar As Interim CFO
Brief: C Rad Q1 EBIT Up At SEK 14.2 Mln